Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Karyopharm Therapeutics Inc. sell Lokrim

Start price
€1.27
05.02.24 / 20%
Target price
-
05.02.25
Performance (%)
-24.67%
Price
€0.96
08.05.24
Summary
This prediction is currently active. The price of Karyopharm Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -24.67%. This prediction currently runs until 05.02.25. The prediction end date can be changed by Lokrim at any time. Lokrim has 20% into this prediction
Performance without dividends (%)
Name 1w 1m
Karyopharm Therapeutics Inc. 0.585% 0.585%
iShares Core DAX® 2.831% 1.236%
iShares Nasdaq 100 2.918% 0.640%
iShares Nikkei 225® 2.007% -2.135%
iShares S&P 500 2.257% 0.451%

According to Lokrim what are the pros and cons of Karyopharm Therapeutics Inc. for the foreseeable future?

Pros
Cons
Risky Investment

Comments by Lokrim for this prediction

In the thread Karyopharm Therapeutics Inc. diskutieren

Sell Karyopharm Therapeutics Inc.

Stopped prediction by Lokrim for Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.24
11.12.21
-
11.12.22
-16.73%
08.12.22

Risky Investment
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.60
08.04.20
-
04.11.21
-60.19%
05.11.21

Risky Investment